The Effect of Radiotherapy After Separation Surgery for Spinal Metastases
Condition(s) studied
Investigational drug(s) / intervention(s)
radiotherapy: The patients receive radiotherapy after the separation surgery.
Study summary
The aim of this clinical study is to explore the impact of whether radiotherapy is administered after spinal metastasis surgery on the prognosis and survival of patients, to describe the clinical outcomes, and to optimize future clinical decisions.
Eligibility
Primary outcome measure(s)
- Progression-Free Survival (PFS) — Baseline up to 24 months.
Time from the date of surgery to the first documented disease progression or death from any cause, whichever occurs first.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Shanghai Changzheng Hospital | Shanghai | Shanghai Municipality | Recruiting |
More Wei Xu trials in China
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07527884 on ClinicalTrials.gov ↗ ← All trials in China